Alembic Pharmaceuticals Ltd Quarterly Results

Gross Sales

1,769.64

1,692.74

1,647.98

1,561.73

1,516.98

Excise Duty

0

0

0

0

0

Net Sales

1,769.64

1,692.74

1,647.98

1,561.73

1,516.98

Other Operating Income

0

0

0

0

0

Other Income

14.19

9.86

30.47

2.42

3.6

Total Income

1,783.83

1,702.6

1,678.45

1,564.15

1,520.58

Total Expenditure

1,498.37

1,432.52

1,408.71

1,324.9

1,257.31

PBIDT

285.46

270.08

269.74

239.25

263.27

Interest

24.52

22.26

18.81

13.18

10.94

PBDT

260.94

247.82

250.93

226.07

252.33

Depreciation

68.99

70.04

70.51

69.04

69.48

Minority Interest Before NP

0

0

0

0

0

Tax

20.64

22.48

40.23

38.82

26.39

Deferred Tax

14.68

17.6

-12.95

-16.33

-21.75

Reported Profit After Tax

156.63

137.7

153.14

134.54

178.21

Minority Interest After NP

-0.26

-0.72

-0.27

-0.17

0

Net Profit after Minority Interest

156.89

138.42

153.41

134.71

178.21

Extra-ordinary Items

0

0

10

0

0

Adjusted Profit After Extra-ordinary item

156.89

138.42

143.41

134.71

178.21

EPS (Unit Curr.)

7.98

7.01

7.79

6.84

9.07

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

39.31

39.31

39.31

39.31

39.31

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.13

15.95

16.36

15.31

17.35

PBDTM(%)

14.74

14.64

15.22

14.47

16.63

PATM(%)

8.85

8.13

9.29

8.61

11.74